According to RadNet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.18115. At the end of 2022 the company had a P/S ratio of 0.7553.
Year | P/S ratio | Change |
---|---|---|
2022 | 0.7553 | -38.27% |
2021 | 1.22 | 29.83% |
2020 | 0.9424 | 6.49% |
2019 | 0.8849 | 73.25% |
2018 | 0.5108 | -2.07% |
2017 | 0.5216 | 53.93% |
2016 | 0.3388 | -4.09% |
2015 | 0.3533 | -30.69% |
2014 | 0.5097 | 435.18% |
2013 | 0.0952 | -36.79% |
2012 | 0.1507 | 17.15% |
2011 | 0.1286 | -32.79% |
2010 | 0.1914 | 35.66% |
2009 | 0.1411 | -39.07% |
2008 | 0.2315 | -72.77% |
2007 | 0.8502 | 20.66% |
2006 | 0.7047 | 569.56% |
2005 | 0.1052 | -37.24% |
2004 | 0.1677 | 16.77% |
2003 | 0.1436 | -39.17% |
2002 | 0.2361 | -31.56% |
2001 | 0.3449 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Quest Diagnostics
DGX | 1.56 | 32.10% | ๐บ๐ธ USA |
![]() LabCorp LH | 1.29 | 9.52% | ๐บ๐ธ USA |
![]() Psychemedics PMD | 1.12 | -5.58% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZ | 1.41 | 19.37% | ๐บ๐ธ USA |